InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Johnson Anne Nagengast. Director active across 1 company, notably ATAI Life Sciences N.V.. In total, 4 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €89k. Activity tracked since 2 April 2024. The latest transaction was filed on 21 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations